Celldex (CLDX)

0.25 -0.01 (3.85%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (6/4/18 *Est.)

Latest Headlines

Form 8-K Celldex Therapeutics, For: Dec 05 December 10, 2018 4:02 PM - SEC Filing Form 4 Celldex Therapeutics, For: Dec 03 Filed by: McMahon Gerald PhD December 4, 2018 7:35 AM - SEC Filing Form 8-K Celldex Therapeutics, For: Nov 27 November 27, 2018 9:19 AM - SEC Filing Analysis: Positioning to Benefit within Celldex Therapeutics, InnSuites Hospitality Trust, Keryx Biopharmaceuticals, EMX Royalty, FTE Networks, and Xinyuan Real Estate — Research Highlights Growth, November 26, 2018 8:35 AM - Globe NewsWire Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting November 10, 2018 8:01 AM - Globe NewsWire Celldex (CLDX) Highlights Promising Interim Data from Phase 1 Study of Differentiated CD40 Agonist CDX-1140 November 9, 2018 8:04 AM - StreetInsider Celldex Presents Promising Interim Data from Phase 1 Study of Differentiated CD40 Agonist CDX-1140 at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting November 9, 2018 8:01 AM - Globe NewsWire Form 10-Q Celldex Therapeutics, For: Sep 30 November 7, 2018 4:11 PM - SEC Filing Form 8-K Celldex Therapeutics, For: Nov 07 November 7, 2018 4:03 PM - SEC Filing Celldex Provides Corporate Update and Reports Third Quarter 2018 Results November 7, 2018 4:01 PM - Globe NewsWire Form 4 Celldex Therapeutics, For: Nov 01 Filed by: McMahon Gerald PhD November 2, 2018 7:51 AM - SEC Filing Form 4 Celldex Therapeutics, For: Oct 01 Filed by: McMahon Gerald PhD October 2, 2018 7:33 AM - SEC Filing Full Article List